NuTide:302: A phase Ib study to assess the safety, pharmacokinetics and clinical activity of the ProTide NUC-3373 when combined with standard agents used in colorectal cancer.
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Beatson West of Scotland Cancer Centre, University of Glasgow, University of Oxford, Vanderbilt University Medical Center, Institut Hospitalier Franco Britannique, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Vanderbilt University, Vanderbilt-Ingram Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2913579983